Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Sponsor
Innovaderm Research Inc. (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05994976
Collaborator
(none)
500
1
60
8.3

Study Details

Study Description

Brief Summary

The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Blood samples collection
  • Procedure: Oral samples collection
  • Procedure: Hair samples collection
  • Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
  • Procedure: Skin surface material samples
  • Procedure: Drainage fluid samples collection
  • Procedure: Stool samples collection

Detailed Description

This study is being conducted to collect samples from subjects with various skin conditions as well as healthy volunteers. Collected samples may be used for different analyses including, but not limited to, biomarker and gene expression analyses.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers for Molecular Characterization of Inflammatory Skin Diseases
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2028
Anticipated Study Completion Date :
Aug 1, 2028

Arms and Interventions

Arm Intervention/Treatment
Healthy volunteers

Healthy adults

Procedure: Blood samples collection
biomarkers and optional genetic analysis

Procedure: Oral samples collection
biomarkers analysis

Procedure: Hair samples collection
biomarkers analysis

Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis

Procedure: Skin surface material samples
biomarkers analysis

Procedure: Drainage fluid samples collection
biomarkers analysis

Procedure: Stool samples collection
biomarkers analysis

Acne

Adult subjects aged 18 to 45 years old with acne

Procedure: Blood samples collection
biomarkers and optional genetic analysis

Procedure: Oral samples collection
biomarkers analysis

Procedure: Hair samples collection
biomarkers analysis

Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis

Procedure: Skin surface material samples
biomarkers analysis

Procedure: Drainage fluid samples collection
biomarkers analysis

Procedure: Stool samples collection
biomarkers analysis

AD

Adult subjects with Atopic Dermatitis (AD)

Procedure: Blood samples collection
biomarkers and optional genetic analysis

Procedure: Oral samples collection
biomarkers analysis

Procedure: Hair samples collection
biomarkers analysis

Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis

Procedure: Skin surface material samples
biomarkers analysis

Procedure: Drainage fluid samples collection
biomarkers analysis

Procedure: Stool samples collection
biomarkers analysis

CHE

Adult subjects with Chronic Hand Eczema (CHE)

Procedure: Blood samples collection
biomarkers and optional genetic analysis

Procedure: Oral samples collection
biomarkers analysis

Procedure: Hair samples collection
biomarkers analysis

Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis

Procedure: Skin surface material samples
biomarkers analysis

Procedure: Drainage fluid samples collection
biomarkers analysis

Procedure: Stool samples collection
biomarkers analysis

HS

Adult subjects with Hidradenitis suppurativa (HS)

Procedure: Blood samples collection
biomarkers and optional genetic analysis

Procedure: Oral samples collection
biomarkers analysis

Procedure: Hair samples collection
biomarkers analysis

Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis

Procedure: Skin surface material samples
biomarkers analysis

Procedure: Drainage fluid samples collection
biomarkers analysis

Procedure: Stool samples collection
biomarkers analysis

PPP

Adult subjects with Palmoplantar pustulosis (PPP)

Procedure: Blood samples collection
biomarkers and optional genetic analysis

Procedure: Oral samples collection
biomarkers analysis

Procedure: Hair samples collection
biomarkers analysis

Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis

Procedure: Skin surface material samples
biomarkers analysis

Procedure: Drainage fluid samples collection
biomarkers analysis

Procedure: Stool samples collection
biomarkers analysis

Psoriasis

Adult subjects with Psoriasis

Procedure: Blood samples collection
biomarkers and optional genetic analysis

Procedure: Oral samples collection
biomarkers analysis

Procedure: Hair samples collection
biomarkers analysis

Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
biomarkers analysis

Procedure: Skin surface material samples
biomarkers analysis

Procedure: Drainage fluid samples collection
biomarkers analysis

Procedure: Stool samples collection
biomarkers analysis

Outcome Measures

Primary Outcome Measures

  1. Exploratory biomarker and gene expression analyses. [Day 1]

  2. Untargeted biomarker approach with gene expression profile of skin samples [Day 1]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
All subjects:
  1. Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.

  2. Subject must be willing to comply with all study procedures and must be available for the duration of the study.

Healthy volunteers:
  1. Male or female subject aged 18 years or older, at the time of consent.

  2. Subject is in good general health, according to the investigator's judgment.

Subjects with Acne:
  1. Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
Subjects with AD:
  1. Male or female subject aged 18 years or older, at the time of consent.

  2. Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.

Subjects with CHE:
  1. Male or female subject aged 18 years or older, at the time of consent.

  2. Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).

Subjects with HS:
  1. Male or female subject aged 18 years or older, at the time of consent.

  2. Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.

Subjects with PPP:
  1. Male or female subject aged 18 years or older at the time of consent.

  2. Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).

Subjects with psoriasis:
  1. Male or female subject aged 18 years or older, at the time of consent.
Exclusion Criteria:
All subjects:
  1. Subject is a female who is pregnant or who is planning to become pregnant during the study.

  2. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Innovaderm Research Inc. Montréal Quebec Canada H2X 2V1

Sponsors and Collaborators

  • Innovaderm Research Inc.

Investigators

  • Principal Investigator: Robert Bissonnette, MD, Innovaderm Research Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Innovaderm Research Inc.
ClinicalTrials.gov Identifier:
NCT05994976
Other Study ID Numbers:
  • INNO-5034
First Posted:
Aug 16, 2023
Last Update Posted:
Aug 22, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2023